title: Nonalcoholic fatty liver disease in severely obese adolescent and adult patients.
abstract: OBJECTIVE
  Nonalcoholic fatty liver disease (NAFLD) is increasingly an indication for liver transplantation in adults. While severe obesity (SO, BMI ≥40 kg m(-2) ) in adults is long standing, it is recent in duration in adolescents. With adolescent obesity on the rise, NAFLD is becoming the most frequent liver disease in adolescents. The hypothesis that SO adolescents and adults have different severity of NAFLD because of longer duration of obesity in SO adults was tested.
  
  
  METHODS
  Preoperative clinical data, NAFLD activity and NASH (Nonalcoholic steatohepatitis) scores from intraoperative liver biopsies were extracted from a prospective database of consecutively operated SO adolescents and adults (n = 24 each). Fasting preoperative serum inflammatory mediators were evaluated by ELISA.
  
  
  RESULTS
  Other than age, baseline BMI, ethnicity and gender distribution, the incidence and extent of dyslipidemia, hypertension, and metabolic syndrome were comparable between groups. Histologic scores for steatosis and inflammation were similar. Adolescents have significantly higher NASH incidence, hepatocyte injury scores and fibrosis. This was associated with higher serum C-reactive protein and sCD14 levels.
  
  
  CONCLUSIONS
  For comparable BMI and metabolic profile, SO adolescents have more advanced liver damage, more severe systemic inflammation, suggesting differences in NAFLD etiologies and more aggressive disease progression in the young obese population.
authors.affiliation: Department of Surgery/Division of Pediatric Surgery, University of Illinois College of Medicine at Peoria, Illinois, USA. aixuan.l.holterman@osfhealthcare.org
authors.forename: Ai-Xuan L
authors.initials: AX
authors.lastname: Holterman
authors.forename: Grace
authors.initials: G
authors.lastname: Guzman
authors.forename: Giamila
authors.initials: G
authors.lastname: Fantuzzi
authors.forename: Huaping
authors.initials: H
authors.lastname: Wang
authors.forename: Kristin
authors.initials: K
authors.lastname: Aigner
authors.forename: Allen
authors.initials: A
authors.lastname: Browne
authors.forename: Mark
authors.initials: M
authors.lastname: Holterman
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D005234:Fatty Liver / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D022781:Hepatocytes / Q000473:pathology; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D008099:Liver / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease; D009767:Obesity, Morbid / Q000150:complications / Q000453:epidemiology*; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D018836:Inflammation Mediators; D002097:C-Reactive Protein